Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Dold, L; Lutz, P; Heine, A; Weismuller, TJ; Strassburg, CP; Spengler, U.
Ruxolitinib for treatment of polycythemia vera and myelofibrosis in patients after liver transplantation
CLIN CASE REP. 2021; 9(9): e04782 Doi: 10.1002/ccr3.4782 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Heine Annkristin
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Although ruxolitinib contributes to immunomodulation and can lead to severe infections, it seems a feasible treatment strategy for patients with polycythemia vera and myelofibrosis after liver transplantation.

Find related publications in this database (Keywords)
liver transplantation
myelofibrosis
polycythemia vera
ruxolitinib
© Med Uni Graz Impressum